IPO-INTA.NS

Chart for IPO-INTA.NS

About

Intas Pharmaceuticals, Ltd. manufactures pharmaceutical products. The Company offers pharmaceuticals products for the segments in neurology, psychiatry, cardiology, diabetology, gastroenterology, urology, ophthalmology, animal healthcare, oncology, biotechnology and orthopaedic. The Company manufactures cytotoxic products. The... (more)
No analyst recommendations are available for IPO-INTA.NS.

Overall

Beta: --
Market Cap (Mil.): --
Shares Outstanding (Mil.): 103.48
Dividend: --
Yield (%): --

Financials

  IPO-INTA.NS Industry Sector
P/E (TTM): -- 38.36 38.84
EPS (TTM): 20.59 -- --
ROI: 16.15 18.99 18.26
ROE: 34.59 19.74 19.12
Search Stocks

Earnings vs. Estimates

No consensus analysis data available.

Analyst Research Reports

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: GlobalData
$125.00
Provider: GlobalData
$125.00
Provider: GlobalData
$125.00
Provider: GlobalData
$250.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks